Veterinary Medicines

Ubrolexin intramammary suspension for lactating dairy cows

Authorised
  • Cefalexin monohydrate
  • KANAMYCIN MONOSULPHATE
Download as PDF

Product identification

Medicine name:
Ubrolexin intramammary suspension for lactating dairy cows
UBROLEXIN SUSPENSION INTRAMAMARIA PARA VACAS LECHERAS EN LACTACIÓN
Active substance:
  • Cefalexin monohydrate
  • KANAMYCIN MONOSULPHATE
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    210.36
    milligram(s)
    /
    1.00
    Syringe
  • KANAMYCIN MONOSULPHATE
    120247.00
    international unit(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        10
        day
      • Milk
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • Cardboard box with 20 single use intramammary syringes and 20 teat wipes (containing isopropanol 70%). Each 10 g syringe contains 12 ml intramammary suspension and consists of a barrel with plunger and sealed sterile tip,all made of low density polyethylene.
  • Cardboard box with 10 single use intramammary syringes and 10 teat wipes (containing isopropanol 70%). Each 10 g syringe contains 12 ml intramammary suspension and consists of a barrel with plunger and sealed sterile tip,all made of low density polyethylene.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Univet Limited
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 1917 ESP
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0221/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Spanish (PDF)
Published on: 16/02/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."